Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
12276
CALL
DELISTED
Open Lending Corp
LPRO
| $26K | ﹤0.01% |
+13,400
| New | +$21.6K |
|
12277
CALL
Fortress Biotech
FBIO
$94.4M
| $25.7K | ﹤0.01% |
13,800
-19,500
| -59% | -$33.8K |
|
12278
TELA Bio
TELA
$31.4M
| $25.5K | ﹤0.01% |
13,169
-77,346
| -85% | -$101K |
|
12279
PUT
MacroGenics
MGNX
$266M
| $25.5K | ﹤0.01% |
21,100
-19,800
| -48% | -$28.7K |
|
12280
Able View Global
ABLV
$48.4M
| $25.5K | ﹤0.01% |
24,496
+3,249
| +15% | +$3.63K |
|
|
CIF
12281
DELISTED
MFS Intermediate High Income Fund
CIF
| $25.3K | ﹤0.01% |
+14,522
| New | +$24.5K |
|
|
MLGO
12282
PUT
MicroAlgo
MLGO
$45.4M
| $25.1K | ﹤0.01% |
+1,643
| New | +$269K |
|
12283
Snail Inc
SNAL
$26.8M
| $25.1K | ﹤0.01% |
+3,666
| New | +$19.3K |
|
12284
CALL
Stereotaxis
STXS
$141M
| $25K | ﹤0.01% |
11,800
-25,200
| -68% | -$51.2K |
|
|
MI
12285
NFT Ltd
MI
$647K
| $24.7K | ﹤0.01% |
+134
| New | +$24.3K |
|
|
BGDE
12286
Big Digital Energy Inc
BGDE
$44.7M
| $24.7K | ﹤0.01% |
+3,253
| New | +$34.1K |
|
|
12287
CALL
MacroGenics
MGNX
$266M
| $24.7K | ﹤0.01% |
20,400
+8,500
| +71% | +$12.3K |
|
|
ASPSW
12288
Altisource Portfolio Solutions SA Net Settle Stakeholder Warrants
ASPSW
$11.4M
| $24.6K | ﹤0.01% |
+49,265
| New | +$23.2K |
|
|
VIVS
12289
VivoSim Labs
VIVS
$3.9M
| $24.6K | ﹤0.01% |
+16,727
| New | +$30.7K |
|
12290
PUT
Clean Energy Fuels
CLNE
$346M
| $24.6K | ﹤0.01% |
12,600
-8,700
| -41% | -$14.8K |
|
|
ARTV
12291
Artiva Biotherapeutics
ARTV
$575M
| $24.3K | ﹤0.01% |
16,121
-8,236
| -34% | -$17.3K |
|
|
LONA
12292
LeonaBio Inc
LONA
$75.5M
| $24.3K | ﹤0.01% |
8,052
+6,177
| +329% | +$17.5K |
|
12293
CALL
Castor Maritime
CTRM
$24.2M
| $24.3K | ﹤0.01% |
11,500
| – | – |
|
|
AP.WS
12294
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
| $24.3K | ﹤0.01% |
1,276,571
| – | – |
|
|
OGG
12295
PUT
Osisko Gold Group
OGG
$976M
| $24.2K | ﹤0.01% |
11,300
+100
| +0.9% | +$185 |
|
|
AUTL
12296
PUT
Autolus Therapeutics
AUTL
$649M
| $24.2K | ﹤0.01% |
10,600
-1,800
| -15% | -$2.98K |
|
12297
PUT
Purple Innovation
PRPL
$20.7M
| $24.1K | ﹤0.01% |
1,320
+192
| +17% | +$3.54K |
|
|
GAU
12298
CALL
Galiano Gold
GAU
$628M
| $24K | ﹤0.01% |
+18,900
| New | +$25.7K |
|
|
ASRT
12299
PUT
DELISTED
Assertio
ASRT
| $24K | ﹤0.01% |
2,500
-4,433
| -64% | -$42.6K |
|
|
CNF
12300
CNFinance Holdings
CNF
$37.1M
| $24K | ﹤0.01% |
3,689
+1,491
| +68% | +$9.22K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.